TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma

TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma

<h4>Aims</h4> <p>Transient receptor potential channel melastatin 4 (TRPM4) is an ion channel that regulates influx of calcium cations (Ca2+). Recent studies suggest that TRPM4 is an oncoprotein and its upregulated transcript level has been reported in diffuse large B-cell lymphoma...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Loo, S, Ch'ng, E, Salleh, M, Banham, A, Pedersen, L, Møller, M, Green, T, Wong, K
Formatua:	Journal article
Argitaratua:	Wiley 2017

Antzeko izenburuak

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas
nork: Loo, SK, et al.
Argitaratua: (2017)

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
nork: Wong, K, et al.
Argitaratua: (2016)

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
nork: Brown, P, et al.
Argitaratua: (2015)

The significance of FOXP1 in diffuse large B-cell lymphoma
nork: Gascoyne, D, et al.
Argitaratua: (2016)

Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma.
nork: Minna Taskinen, et al.
Argitaratua: (2014-01-01)

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
nork: Zainuddin, Norafiza, et al.
Argitaratua: (2008)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
nork: Rong Shen, et al.
Argitaratua: (2023-04-01)

Evaluation of immunohistochemical subtypes in diffuse large B-cell lymphoma and its impact on survival
nork: Anamika Dwivedi, et al.
Argitaratua: (2015-01-01)

Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma
nork: Leo Meriranta, et al.
Argitaratua: (2017-05-01)

Serologic detection of diffuse large B-cell lymphoma-associated antigens.
nork: Liggins, A, et al.
Argitaratua: (2004)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
nork: Barrans, S, et al.
Argitaratua: (2004)

Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry
nork: Rebekka Reber, et al.
Argitaratua: (2013-04-01)

Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
nork: Sneha Samir Babaria, et al.
Argitaratua: (2025-01-01)

Pathway activation patterns in diffuse large B-cell lymphomas.
nork: Bentink, S, et al.
Argitaratua: (2008)

Low GILT expression is associated with poor patient survival in diffuse large B-cell lymphoma
nork: Hannah ePhipps-Yonas, et al.
Argitaratua: (2013-12-01)

Diffuse b-cell lymphoma
nork: C Grosu, et al.
Argitaratua: (2011-03-01)

Analysis of Diffuse Large B Cell Lymphoma using Immunohistochemistry to Identify Double Expressor Diffuse Large B Cell Lymphoma among Germinal Centre and Non Germinal Centre B Cell Subtypes
nork: E R Jyothi Rani, et al.
Argitaratua: (2024-08-01)

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.
nork: Nyman, H, et al.
Argitaratua: (2009)

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
nork: Choi, W, et al.
Argitaratua: (2009)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
nork: Barrans, S, et al.
Argitaratua: (2005)

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
nork: Kizhakeyil, A, et al.
Argitaratua: (2021)

The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
nork: Sylvain Mareschal, et al.
Argitaratua: (2011-12-01)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
nork: Camilleri, E, et al.
Argitaratua: (2012)

An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm
nork: Anuradha Ananthamurthy, et al.
Argitaratua: (2024-07-01)

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
nork: Lucía Pedrosa, et al.
Argitaratua: (2021-01-01)

Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma
nork: Joo Y. Song, et al.
Argitaratua: (2023-01-01)

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.
nork: Lawrie, C, et al.
Argitaratua: (2007)

Diffuse large B-cell lymphoma
nork: Gatter, K, et al.
Argitaratua: (2010)

Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma
nork: Antonio Lopez, et al.
Argitaratua: (2023-01-01)

B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt’s lymphoma
nork: E A Baryakh, et al.
Argitaratua: (2015-04-01)

Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
nork: Ait-Tahar, K, et al.
Argitaratua: (2009)

A unified 35-gene signature for both subtype classification and survival prediction in diffuse large B-cell lymphomas.
nork: Yu-Dong Cai, et al.
Argitaratua: (2010-09-01)

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
nork: Matías S. Mendeville, et al.
Argitaratua: (2025-01-01)

Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified
nork: Shoko Nakayama, et al.
Argitaratua: (2017-03-01)

High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma
nork: Feras Zaiem, et al.
Argitaratua: (2020-10-01)

P1227: COMPREHENSIVE MOLECULAR SUBTYPING OF DIFFUSE LARGE B-CELL LYMPHOMA CELL LINES AND ASSOCIATION WITH TAFASITAMAB ACTIVITY
nork: Arshi Arora, et al.
Argitaratua: (2023-08-01)

Aggressive B-cell lymphoma subtyping: a pathologists viewpoint
nork: Daphne de Jong
Argitaratua: (2019-06-01)

Lenalidomide in Diffuse Large B-Cell Lymphomas
nork: Annalisa Chiappella, et al.
Argitaratua: (2012-01-01)

Lenalidomide in Diffuse Large B-Cell Lymphoma
nork: Catherine Thieblemont, et al.
Argitaratua: (2012-01-01)

Refractory diffuse large B-cell Lymphoma
nork: Hajar Masrour, et al.
Argitaratua: (2023-01-01)